- Home
- QNCX vs SPCB Comparison
QNCX vs SPCB Comparison
Compare QNCX & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SPCB
- Stock Information
- Founded
- QNCX 2012
- SPCB 1988
- Country
- QNCX United States
- SPCB Israel
- Employees
- QNCX N/A
- SPCB N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SPCB Semiconductors
- Sector
- QNCX Health Care
- SPCB Technology
- Exchange
- QNCX Nasdaq
- SPCB Nasdaq
- Market Cap
- QNCX 47.7M
- SPCB 53.3M
- IPO Year
- QNCX 2019
- SPCB N/A
- Fundamental
- Price
- QNCX $1.64
- SPCB $9.72
- Analyst Decision
- QNCX Strong Buy
- SPCB Strong Buy
- Analyst Count
- QNCX 5
- SPCB 1
- Target Price
- QNCX $8.00
- SPCB $18.00
- AVG Volume (30 Days)
- QNCX 353.3K
- SPCB 166.8K
- Earning Date
- QNCX 08-12-2025
- SPCB 08-14-2025
- Dividend Yield
- QNCX N/A
- SPCB N/A
- EPS Growth
- QNCX N/A
- SPCB N/A
- EPS
- QNCX N/A
- SPCB 1.89
- Revenue
- QNCX N/A
- SPCB $27,831,000.00
- Revenue This Year
- QNCX N/A
- SPCB $2.73
- Revenue Next Year
- QNCX N/A
- SPCB $22.87
- P/E Ratio
- QNCX N/A
- SPCB $5.16
- Revenue Growth
- QNCX N/A
- SPCB 2.90
- 52 Week Low
- QNCX $0.51
- SPCB $2.55
- 52 Week High
- QNCX $2.45
- SPCB $18.95
- Technical
- Relative Strength Index (RSI)
- QNCX 64.95
- SPCB 47.89
- Support Level
- QNCX $1.48
- SPCB $9.61
- Resistance Level
- QNCX $1.68
- SPCB $11.14
- Average True Range (ATR)
- QNCX 0.14
- SPCB 0.68
- MACD
- QNCX 0.02
- SPCB -0.22
- Stochastic Oscillator
- QNCX 85.71
- SPCB 17.44
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.